Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-19,246
Closed -$236K 4035
2025
Q1
$236K Sell
19,246
-9,554
-33% -$146K ﹤0.01% 3744
2024
Q4
$386K Sell
28,800
-62
-0.2% -$705 ﹤0.01% 3618
2024
Q3
$271K Buy
+28,862
New +$292K ﹤0.01% 3673
2020
Q4
Sell
-9,994
Closed -$1.95M 3788
2020
Q3
$1.95M Buy
+9,994
New +$2.41M ﹤0.01% 2684

Other funds holding GOCO

Ameriprise's GOCO Position: Q2 2025 in Review

Ameriprise sold out of GoHealth (GOCO) in Q2 2025, closing a stake of 19,246 shares — an estimated $236K sold.

Ameriprise first reported a position in GOCO in Q3 2020 and held it in 4 quarters. The position peaked at $1.95M in Q3 2020. 55 funds tracked by Wall St. Rank hold GOCO as of Q2 2025.

  • Ameriprise reported no remaining GoHealth position as of Q2 2025 after selling out during the quarter.
  • Ameriprise sold 19,246 GoHealth shares in Q2 2025, an estimated $236K.
  • Ameriprise first reported a position in GoHealth in Q3 2020 and held it in 4 quarters.
  • Ameriprise's GoHealth position peaked at $1.95M in Q3 2020.
  • 55 funds tracked by Wall St. Rank held GoHealth as of Q2 2025.

Based on Ameriprise's 13F filing for Q2 2025, filed 14 Aug 2025.